Health FDA Approves Ctexli: First Treatment for Rare Lipid Storage Disorder CTXBy Stanley SimalsFebruary 25, 2025 Health 3 Mins Read The FDA has recently approved a groundbreaking treatment for cerebrotendinous xanthomatosis (CTX), a rare genetic disorder that interferes with the…
Health FDA Approves Ctexli: A New Treatment for Cerebrotendinous Xanthomatosis (CTX)By Allan OmbugeFebruary 25, 2025 Health 3 Mins Read The U.S. Food and Drug Administration (FDA) has approved a new oral medication, Ctexli, for the treatment of cerebrotendinous xanthomatosis…
